BioCurate Pty Ltd

Andy Allen and Tifelle Reisinger joined the 2024 Innovate2Translate symposium today. BioCurate Pty Ltd thanks the Melbourne Therapeutics Organising Committee for an excellent symposium! BioCurate Pty Ltd sponsored the Funders panel session facilitated by Chris Porter (Monash Institute of Pharmaceutical Sciences ), with our own Andy Allen, as well as Michael Bettess (Brandon Capital), Siro Perez (IP Group plc), Michelle H. (Tin Alley Ventures) and Joey Man (Tenmile). The session sparked engaging and insightful conversations with great advice from the panel. Few takeaways on what these funders are looking for and some tips. - Differentiation: what makes your product special and have IP to protect it. - Sound path to market with clinical input and regulatory strategy - Biotech is a team sport. Build a collaborative team with drug development experience, and leverage the expertise and network of your investors - Building a company is a long but rewarding game. Incentivise founders to have skin in the game and keep them involved as entrepreneurs or scientific advisors - Investors talk to each other regularly about de-risking projects together to significantly move the needle towards the next inflection point - Value in single asset versus platform - Invest in first-in-class versus best-in-class molecules with transformational improvement for patients #I2T2024 #BioCurate #Innovation #drugtranslation #MedicalResearch

Are you interested in translating or commercialising your research? Join Andy Allen and Tifelle Reisinger at 2024 Innovate2Translate symposium at the Woodward Centre on November 21st to hear research and biotech stories from across Parkville. 🌟 Invited speakers from across the Melbourne biotech sector 🏆Updates from past MTx pitch competition winners 🎙️Expert panel on research commercialisation BioCurate Pty Ltd is proud to sponsor the Funders panel session with our own Andy Allen, as well as Michael Bettess (Brandon Capital), Siro Perez (IP Group plc), Calum McConville (Tin Alley Ventures), Joey Man (Tenmile). register here: https://lnkd.in/ec6HM-Pp #I2T2024 #BioCurate #Innovation #drugtranslation #MedicalResearch

BioCurate Pty Ltd was a Gold Sponsor of the Victorian Muscle Network (VMN), fostering collaboration and innovation among early career researchers. Thank you to the VMN committee (Benoit Haerlingen, Leon Kiriaev) for organising an engaging symposium and fostering collaborations - we're shaping tomorrow's muscle breakthroughs! 🧬🔬 BioCurate’s Dr Frederico Calhabeu and Dr Tifelle Reisinger attended on our behalf. Congratulations to the winners of our sponsored awards: 🏆 BioCurate Best Oral Presentation (Postdoc) Prize, Bhavana N. (Monash University). 🏆 BioCurate Best Oral Presentation (Student) Prize, Hamizan Khabib Hamizan Khabib (University of Melbourne) 🏆 BioCurate Runner up Best Oral Presentation (Postdoc) Prize, Kristy Swiderski (University of Melbourne) 🏆 BioCurate Runner up Best Oral Presentation (Student) Prize, Wenlan Li (The University of Melbourne) @VicMuscleNet #vmn2024 #EarlyCareerScientists #EarlyCareerResearchers

BioCurate Pty Ltd is proud to sponsor the Victorian Muscle Network (VMN) 7th Annual Symposium, hosted by Murdoch Children's Research Institute (MCRI). Join Dr Frederico Calhabeu and Dr Tifelle Reisinger on Friday 8th November 2024 to explore cutting-edge skeletal, cardiac and smooth muscle research at The University of Melbourne (Parkville Campus).

As we wrap up an incredible experience at AusBiotech 2024, we want to extend our thanks to everyone who participated and engaged with the team: Kathy Nielsen, Francis Kirby, Frederico Calhabeu, Tifelle Reisinger 🌟 This event highlighted the importance of collaboration in driving innovation within the biotech sector—an ethos that aligns perfectly with BioCurate's mission. Our commitment to translating exceptional medical research into viable therapeutic candidates was at the forefront of our discussions. Together, we can bridge the gap between academia and industry, fostering advancements that lead to impactful health solutions. Key highlights from our time at AusBiotech include: 📢 Engaging conversations about enhancing the quality and rate of drug translation. 🔬 Networking with industry leaders dedicated to building a robust biotech ecosystem in Australia. 💊 Sharing insights on how we can collectively support the development of groundbreaking therapies. Next steps for us include taking these conversations global, with Dr Eric Hayes attending #BioEurope in Stockholm 4-6 Nov. Stay tuned for more! #AusBio2024 #BioCurate #BiotechInnovation  Victorian Government

Just wrapped up an insightful panel on 'Considerations when investing in early-stage university spin-outs' at #AusBio2024! 🎉 Dr Kathy Nielsen (BioCurate Pty Ltd), shared expertise alongside Dr Michael Bettess (Brandon Capital), Dr Aoife Cullen (Monash Innovation, Monash University), Dr Amir Zalcenstein (SYNthesis BioVentures), with Dr John Kurek (Uniseed) as Chair. Exciting times ahead #AusBio24! #BioInnovation #UniversitySpinouts Victorian Government

Join us for the "Considerations when investing in early-stage university spin-outs" panel today at 2:20 PM - 3:05 PM! 🕑 Dr Kathy Nielsen, CEO at BioCurate Pty Ltd, will be sharing her expertise alongside: 🔬 Dr Michael Bettess (Brandon Capital)  🧪 Dr Aoife Cullen (Monash Innovation)  🔬 Dr Amir Zalcenstein (SYNthesis BioVentures) 💼 with Dr John Kurek (Uniseed) as Chair This power-packed panel will explore the ins and outs of investing in university spin-outs, covering everything from pipeline potential to managing expectations. 🎓💡 Don't miss this chance to gain valuable insights into early-stage life science investments! 💪🏼 #AusBio2024 #BioCurate #InvestmentInsights Victorian Government

AusBiotech 2024 is well underway! Visit the BioCurate team at the Victorian Government Pavilion booth #4. We look forward to forming new connections with the sector and deepening our established partnerships. To keep up to date through the conference, follow us on Twitter @BioCurate. #AusBio2024 Tifelle Reisinger Kathy Nielsen Frederico Calhabeu Francis Kirby

AusBiotech 2024 has officially kicked off today! Don't miss the opportunity to visit BioCurate at the Victorian Government booth #4. 🤝 Our team is also available to connect through the AusPartnering program. Dr Kathy Nielsen, CEO Dr Francis Kirby, Partnerships and Strategy Manager Dr Frederico Calhabeu, Director of Cell and Gene Therapies Dr Tifelle Reisinger, Associate Director, Medicinal Chemistry Discovery and Stakeholder Management 📢 Dr Kathy Nielsen will be participating in the panel "Considerations when investing in early-stage university spin-outs" on Thursday, October 31, from 2:20 PM - 3:05 PM. Reach out to connect and share insights around the future possibilities of our industry! #AusBio2024 #Biotechnology #LifeSciences #Innovation #Melbourne 

Thrilled to announce our small molecule drug discovery arm #QEDDI is partnering with BioCurate Pty Ltd to develop a potential new treatment for pain and a safer alternative to opioids. Great to have this exciting partnership launched during AusBiotech #AusBiotech2024! 💊💊💊 #QEDDI #UniQuest #drugdiscovery #smallmolecules #biomedicalresearch #collaboration #drugtranslation #neuropathicpain